ELAVL4 and early-onset autosomal dominant Alzheimer disease: Several studies have shown that ELAVL4 involved in the pathogenesis of neurodegenerative diseases, such as Alzheimer’s disease (Kang et al., 2014), Parkinson’s disease (Noureddine et al., 2005), and amyotrophic lateral sclerosis (Dell’Orco et al., 2021).